About the EMCDDA
The EMCDDA will become the EUDA on 2 July 2024
The EMCDDA has been granted stronger powers to tackle current and future drug problems. The new Regulation of the European Parliament and of the Council, revises the mandate of the EMCDDA, in order to keep pace with an ever more complex and rapidly changing drug phenomenon. The EMCDDA will become the European Union Drugs Agency (EUDA) on 2 July 2024, the day on which the regulation enters into application.
Learn more in this new release.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the Europe. Based in Lisbon, Portugal, we provide independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. Our work contributes to EU and national policies to protect Europe’s citizens from drug-related harms. We are an agency of the European Union.
Mission
The EMCDDA supports EU and national policymaking by providing evidence-based information on drugs, drug addiction and their consequences.
Organisation
Information about the EMCDDA's organisational structure and its statutory bodies.
Partners
Cooperation with EU institutions, the Reitox network and regional and international organisations has been an important part of the EMCDDA’s work since its creation in 1993
Useful documents and resources about the EMCDDA
- EMCDDA work programmes
- EMCDDA budgets
- EMCDDA annual accounts
- EMCDDA general report of activities
- EMCDDA founding regulation
- Public access to documents
- European code of good administrative behaviour
- Public service principles
- Conflicts of interest
- EMCDDA interaction with interest representatives
- EMCDDA financial regulation
- Sustainability at the EMCDDA